“Can evidence-based medicine survive in a pandemic?”

The Covid-19 pandemic emerged and consumed over half a million lives within 6 months. There has been an unprecedented response from the medical research community but dissemination of data has often occurred via media announcements and pre-prints without the usual checks of the peer review process. Has this served us well under the circumstances? Or should we do things differently in future?

Read the QJM article annoucing the webinar “can evidence-based medicine survive in a pandemic?” Christian Delles, Colin M Dayan, Anna F Dominiczak, Seamas C Donnelly, Alan D Irvine

QJM

The Programme: Wednesday, 2 September, 2020

17.00-17.05 Setting the scene: introduction from the Secretary of the AoP (Co-Chair)
Professor Christian Delles
Secretary, Association of Physicians of Great Britain & Ireland
Professor and Consultant Physician at the Institute for Cardiovascular and Medical Sciences,
University of Glasgow
Professor Alan Irvine (Co-Chair)
Executive Committee Member, Association of Physicians of Great Britain & Ireland
Professor in Dermatology, Trinity College Dublin
17.05-17.10 Immediate pandemic responses – history and behavioural perspectives
Dr Ida Milne
Pandemic Social Historian, Carlow College, Ireland
17.10-17.15 Prescription panic in a pandemic – prescribing in the USA in March /April 2020
Dr Haider Warriach
Department of Medicine, VA Boston Healthcare System, Boston, Massachusetts
17.15-17.25 Measuring the immunological evidence in COVID-19
Professor Katja Simon and Mr Felix Richter
Kennedy Institute of Rheumatology, University of Oxford
Professor Awen Gallimore
Cardiff University School of Medicine
17.25-17.30 Reporting the RECOVERY Trial
Professor Peter Horby
Nuffield Dept of Medicine, University of Oxford
17.30-17.35 Pre-prints – for good or ill?
Mr Jonathan Schultz
Director, Journal Operations, American Heart Association
17.35-18.00 Panel Discussion
Discussant
Professor Colin Dayan
Professor of Clinical Diabetes and Metabolism, Cardiff University